{"id":5969,"date":"2026-10-12T15:45:08","date_gmt":"2026-10-12T13:45:08","guid":{"rendered":"https:\/\/blog.lallianse.com\/?p=5969"},"modified":"2026-10-12T15:45:10","modified_gmt":"2026-10-12T13:45:10","slug":"wmaa-by-inspirit-partners","status":"publish","type":"post","link":"https:\/\/blog.lallianse.com\/index.php\/en\/wmaa-by-inspirit-partners\/","title":{"rendered":"WMAA by Inspirit Partners"},"content":{"rendered":"\n

Healthcare in Europe: opportunities for M&A?<\/mark>

This was one of the key questions at the heart of the dialogue held last Friday for the World M&A Alliance, organized by Inspirit Partners. It was a discussion orchestrated and moderated by Julie Rachline, featuring insights from: <\/p>\n\n\n\n

Gr\u00e9goire Chauvi\u00e8re Le Drian<\/a> – European Investment Bank (EIB)<\/a>
Lo\u00efc Gonnet<\/a> – Head of M&A at Sanofi<\/a>,
Benoit Varichon<\/a> – partner at ARCHIMED<\/a>
Pascal Raidron<\/a> – founder of EIGHT ADVISORY<\/a> <\/p>\n\n\n\n

Beyond the specific challenges and diverse realities of the healthcare sector, M&A activity in this field is particularly dynamic and efficient, yet grounded in practical realities: a deal requires foresight and is built on human relationships and a nuanced, local understanding\u2014on both the buyer and seller sides. Culture and local dynamics are crucial; in healthcare, transactions cannot be conceived in isolation from their ecosystem. <\/p>\n\n\n\n

It is precisely at the intersection of these factors that LallianSe supports and connects players in the sector.

Julie Rachline<\/a> Shahrzad Moradi<\/a> Maryline BROWNE-DIGUERHER<\/a> Thierry Hassanaly<\/a> Nicolas JULLIAN<\/a><\/p>\n\n\n\n

\n\n\n